Dr. Michael Scott Berkoben, MD

Dr. Berkoben practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Berkoben's NPI, 1821171067, was assigned on October 23, 2006. Dr. Berkoben graduated from Perelman School of Medicine - Philadelphia in 1986. Dr. Berkoben holds North Carolina license 36653.

Dr. Berkoben's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Berkoben's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Berkoben to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berkoben practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Berkoben's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Berkoben is board certified in internal medicine by the American Board of Internal Medicine. Dr. Berkoben is licensed in North Carolina.

Dmand AI lists acute kidney failure, chronic kidney disease and kidney disease among the conditions Dr. Berkoben treats.

CMS data shows 95 Medicare services from Dr. Berkoben across 3 procedure codes in 2024, for 57 Medicare patients. Medicare paid $5,686 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Dr. Berkoben in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 7.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berkoben's median patient age at 68, with 24% women.

In 2024, Dr. Berkoben wrote 450 Medicare Part D claims for 74 patients. 98% of them were for generic drugs. CMS names the drug for 347 of them, across 12 drugs with 11 or more claims each, at $5,378 in total drug cost. In 2023, CMS named 675 claims across 17 drugs.

Dmand AI links 9 papers to Dr. Berkoben in 2019. The most frequent topics are Renal Dialysis, Calcitriol and Calcium. Dr. Berkoben has published most often in J Am Soc Nephrol. Dr. Berkoben's most frequent co-authors are Alex James Brown, MD, David W. Butterly and Robert J. Heyka, MD.

CMS Open Payments shows 4 general payments to Dr. Berkoben from 3 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $169.

Dr. Berkoben graduated from Perelman School of Medicine - Philadelphia in 1986.

Dr. Berkoben is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.